ArticleExperimental and therapeutic medicine2021

The designed NF-κB inhibitor, DHMEQ, inhibits KISS1R-mediated invasion and increases drug-sensitivity in mouse plasmacytoma SP2/0 cells.

Yinzhi Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.